Michael S. Wyzga, Executive VP and CFO at GENZYME CORP (GENZ), sold 5,068 shares at $45.63 ($231K) on 2010-05-25, disclosed to the SEC on 2010-05-26.
Open-market sale of $231k GENZ by Executive VP and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| EXAS | SELL | 2019-08-02 | $590K | — | Filing → |
| EXAS | SELL | 2019-03-01 | $48K | — | Filing → |
| EXAS | SELL | 2018-08-30 | $369K | — | Filing → |